Considerations in Genomic Therapy Matching

To the Editor Lin et al1 report an important analysis of genomic therapy matching in rare and refractory cancers. The finding that improved survival was seen with clinically supported matches but not with investigational tiers is particularly interesting and clinically relevant.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2026-07-23
DOI
https://doi.org/10.1001/jamaoncol.2026.2248
Primary Topic
Genomic variations and chromosomal abnormalities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Considerations in Genomic Therapy Matching

Polina Shilo
JAMA Oncology
Genomic variations and chromosomal abnormalities
article

Considerations in Genomic Therapy Matching

Polina Shilo
article en

Abstract

To the Editor Lin et al1 report an important analysis of genomic therapy matching in rare and refractory cancers. The finding that improved survival was seen with clinically supported matches but not with investigational tiers is particularly interesting and clinically relevant.

JAMA Oncology
Saint Petersburg State Pediatric Medical University (RU)
Openalex Percentile: Top 9%
Genomic variations and chromosomal abnormalities
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Considerations in Genomic Therapy Matching — Polina Shilo · JAMA Oncology (2026) | TGRS Research Map | TGRS